Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
48 participants
INTERVENTIONAL
2012-09-27
2022-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To assess the effects of supervised exercise in women with GDM, 48 women with gestational diabetes, diagnosed between the 18th and 28th week of gestation, will be recruited, after exclusion of subjects with contraindications to exercise. These subjects will be randomly assigned to two groups: structured exercise intervention or standard care.
Women in the intervention group will perform low intensity aerobic exercise three times per week at 30% HRR (heart rate reserve), under continuous heart rate monitoring. Duration of each session will progress from 26 minutes the first week to 40 minutes (increasing 2 min/week). Women in the control group will receive standard diet and physical exercise recommendations.
In all women, clinical, metabolic and anthropometric features will be assessed before, during and at the end of the study. Newborn data will also be collected.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Application of Aerobic and Resistance Exercise in Blood Glucose Control in Pregnant Women With GDM
NCT05901402
Evaluation of Exercise, in Addition to Diet, in Women With Gestational Diabetes
NCT03174340
Acute Effects of an Aquatic Physical Exercise on Glycemic Control of Gestational Diabetes
NCT02931656
The Acute Effect of Physical Activity on Blood Glucose in Pregnant Women
NCT03644238
Exercise in Pregnant Women With Gestational Diabetes
NCT04145479
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Supervised exercise intervention
Women in the intervention group will perform low intensity aerobic exercise three times per week at 30% HRR (Heart Rate Reserve), under continuous heart rate monitoring. Duration of each session will progress from 26 minutes the first week to 40 minutes (by increasing 2 min/week).
Aerobic exercise
Current standard of care
Women in the control group will receive standard physical exercise recommendations.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Aerobic exercise
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Gestational diabetes diagnosis between 18th and 28th week of gestation,
* Caucasian.
Exclusion Criteria
* Restricted lung disease,
* Incompetent cervix/cerclage,
* Persistent second or third trimester bleeding,
* Placenta previa,
* Threatened preterm labor,
* Ruptured membranes,
* Preeclampsia,
* Hypertension,
* Severe anemia,
* Cardiac arrhythmias,
* History of epilepsy,
* Chronic bronchitis,
* Orthopedic limitations,
* Overt hyperthyroidism/ hypothyroidism,
* Type 1 diabetes mellitus,
* Drugs that interfere with metabolic control (such as cortisone)
18 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universita di Verona
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Paolo Moghetti
Associate Prof.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Paolo Moghetti, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Verona and Azienda Ospedaliera Universitaria Integrata of Verona
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Endocrinology, Diabetes and Metabolism Section, Department of Medicine, University of Verona and Azienda Ospedaliera Universitaria Integrata of Verona
Verona, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2152
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.